SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jenks Lori

(Last)

(First)

(Middle)

EMERALD EXPOSITIONS EVENTS, INC.

31910 DEL OBISPO STREET, SUITE 200

(Street)

SAN JUAN CAPISTRANO

92675

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2017

3. Issuer Name and Ticker or Trading Symbol
Emerald Expositions Events, Inc. [ EEX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP - Operations

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	13,125	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	09/04/2023	Common Stock	71,875	$8	D
Stock Option (Right to Buy)	⁽²⁾	09/04/2023	Common Stock	31,250	$12	D
Stock Option (Right to Buy)	⁽²⁾	09/04/2023	Common Stock	31,250	$16	D
Stock Option (Right to Buy)	⁽³⁾	02/26/2024	Common Stock	3,750	$8	D
Stock Option (Right to Buy)	⁽⁴⁾	04/22/2024	Common Stock	26,625	$8	D
Stock Option (Right to Buy)	⁽⁵⁾	04/22/2024	Common Stock	13,250	$12	D
Stock Option (Right to Buy)	⁽⁵⁾	04/22/2024	Common Stock	13,250	$16	D
Stock Option (Right to Buy)	⁽⁶⁾	12/15/2024	Common Stock	20,375	$10.4	D
Stock Option (Right to Buy)	⁽⁷⁾	12/15/2024	Common Stock	10,125	$12	D
Stock Option (Right to Buy)	⁽⁷⁾	12/15/2024	Common Stock	10,125	$16	D

Explanation of Responses:

1. This option is vested with respect to 43,125 underlying shares and will vest with respect to the remaining 28,750 underlying shares in equal installments on September 4, 2017 and September 4, 2018.

2. This option is vested with respect to 18,750 underlying shares and will vest with respect to the remaining 12,500 underlying shares in equal installments on September 4, 2017 and September 4, 2018

3. This option is vested with respect to 2,250 underlying shares and will vest with respect to the remaining 1,500 underlying shares in equal installments on February 26, 2018 and February 26, 2019.

4. This option is vested with respect to 15,975 underlying shares and will vest with respect to the remaining 10,650 underlying shares in equal installments on April 22, 2018 and April 22, 2019.

5. This option is vested with respect to 7,950 underlying shares and will vest with respect to the remaining 5,300 underlying shares in equal installments on April 22, 2018 and April 22, 2019.

6. This option is vested with respect to 8,150 underlying shares and will vest with respect to the remaining 12,225 underlying shares in equal installments on December 15, 2017, December 15, 2018 and December 15, 2019.

7. This option is vested with respect to 4,050 underlying shares and will vest with respect to the remaining 6,075 underlying shares in equal installments on December 15, 2017, December 15, 2018 and December 15, 2019.

	/s/ David Gosling, Attorney-in-Fact for Lori Jenks	04/28/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.